715220007: Tenofovir alafenamide (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Reverse transcriptase inhibitor\Tenofovir alafenamide (substance)
\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Tenofovir alafenamide (substance)

\Drug or medicament (substance)\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Tenofovir alafenamide (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic ester (substance)\Tenofovir alafenamide (substance)

\Ester\Carboxylic ester (substance)\Tenofovir alafenamide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3301911010 Tenofovir alafenamide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3301912015 Tenofovir alafenamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Tenofovir alafenamide (substance)	Is a	Tenofovir (substance)	false	Inferred relationship	Some
Tenofovir alafenamide (substance)	Has disposition (attribute)	Reverse transcriptase inhibitor (disposition)	true	Inferred relationship	Some
Tenofovir alafenamide (substance)	Is a	Carboxylic ester (substance)	true	Inferred relationship	Some
Tenofovir alafenamide (substance)	Is a	Transferase inhibitor	false	Inferred relationship	Some
Tenofovir alafenamide (substance)	Is modification of (attribute)	Tenofovir (substance)	true	Inferred relationship	Some
Tenofovir alafenamide (substance)	Is a	Reverse transcriptase inhibitor	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has active ingredient	False	Tenofovir alafenamide (substance)	Inferred relationship	Some	5
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Tenofovir alafenamide (substance)	Inferred relationship	Some	5
Tenofovir alafenamide fumarate (substance)	Is a	False	Tenofovir alafenamide (substance)	Inferred relationship	Some
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Tenofovir alafenamide (substance)	Inferred relationship	Some	4
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Tenofovir alafenamide (substance)	Inferred relationship	Some	4
Tenofovir alafenamide fumarate (substance)	Is modification of (attribute)	True	Tenofovir alafenamide (substance)	Inferred relationship	Some
Product containing precisely tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Tenofovir alafenamide (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 mg oral tablet	Has basis of strength substance (attribute)	True	Tenofovir alafenamide (substance)	Inferred relationship	Some	2
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet	Has basis of strength substance (attribute)	True	Tenofovir alafenamide (substance)	Inferred relationship	Some	2
Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet	Has basis of strength substance (attribute)	True	Tenofovir alafenamide (substance)	Inferred relationship	Some	2
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet	Has basis of strength substance (attribute)	True	Tenofovir alafenamide (substance)	Inferred relationship	Some	3

Reference Sets

Description inactivation indicator reference set